Rory Stark
Rory Stark
University of Cambridge, Cancer Research UK Cambridge Institute
Verified email at - Homepage
Cited by
Cited by
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
CS Ross-Innes, R Stark, AE Teschendorff, KA Holmes, HR Ali, ...
Nature 481 (7381), 389-393, 2012
RNA sequencing: the teenage years
R Stark, M Grzelak, J Hadfield
Nature Reviews Genetics 20 (11), 631-656, 2019
Progesterone receptor modulates ERα action in breast cancer
H Mohammed, IA Russell, R Stark, OM Rueda, TE Hickey, GA Tarulli, ...
Nature 523 (7560), 313-317, 2015
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
CE Massie, A Lynch, A Ramos‐Montoya, J Boren, R Stark, L Fazli, ...
The EMBO journal 30 (13), 2719-2733, 2011
Piwi and piRNAs act upstream of an endogenous siRNA pathway to suppress Tc3 transposon mobility in the Caenorhabditis elegans germline
PP Das, MP Bagijn, LD Goldstein, JR Woolford, NJ Lehrbach, ...
Molecular cell 31 (1), 79-90, 2008
DiffBind: differential binding analysis of ChIP-Seq peak data
R Stark, G Brown
R package version 100 (4.3), 2011
The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man
NL Sharma, CE Massie, A Ramos-Montoya, V Zecchini, HE Scott, ...
Cancer cell 23 (1), 35-47, 2013
GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility
V Theodorou, R Stark, S Menon, JS Carroll
Genome research 23 (1), 12-22, 2013
Cooperative interaction between retinoic acid receptor-α and estrogen receptor in breast cancer
CS Ross-Innes, R Stark, KA Holmes, D Schmidt, C Spyrou, R Russell, ...
Genes & development 24 (2), 171-182, 2010
Independence of repressive histone marks and chromatin compaction during senescent heterochromatic layer formation
T Chandra, K Kirschner, JY Thuret, BD Pope, T Ryba, S Newman, ...
Molecular cell 47 (2), 203-214, 2012
Integration of copy number and transcriptomics provides risk stratification in prostate cancer: a discovery and validation cohort study
H Ross-Adams, AD Lamb, MJ Dunning, S Halim, J Lindberg, CM Massie, ...
EBioMedicine 2 (9), 1133-1144, 2015
Impact of artifact removal on ChIP quality metrics in ChIP-seq and ChIP-exo data
TS Carroll, Z Liang, R Salama, R Stark, I de Santiago
Frontiers in genetics 5, 75, 2014
BayesPeak: Bayesian analysis of ChIP-seq data
C Spyrou, R Stark, AG Lynch, S Tavaré
BMC bioinformatics 10 (1), 1-17, 2009
5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer
S Uribe-Lewis, R Stark, T Carroll, MJ Dunning, M Bachman, Y Ito, L Stojic, ...
Genome biology 16 (1), 1-15, 2015
Latent regulatory potential of human-specific repetitive elements
MC Ward, MD Wilson, NL Barbosa-Morais, D Schmidt, R Stark, Q Pan, ...
Molecular cell 49 (2), 262-272, 2013
Nuclear ARRB 1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer
V Zecchini, B Madhu, R Russell, N Pértega‐Gomes, A Warren, E Gaude, ...
The EMBO journal 33 (12), 1365-1382, 2014
BayesPeak—an R package for analysing ChIP-seq data
J Cairns, C Spyrou, R Stark, ML Smith, AG Lynch, S Tavaré
Bioinformatics 27 (5), 713-714, 2011
Choline kinase alpha as an androgen receptor chaperone and prostate cancer therapeutic target
M Asim, CE Massie, F Orafidiya, N Pértega-Gomes, AY Warren, ...
Journal of the National Cancer Institute 108 (5), djv371, 2016
The ETS family member GABPα modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancer
NL Sharma, CE Massie, F Butter, M Mann, H Bon, A Ramos-Montoya, ...
Nucleic acids research 42 (10), 6256-6269, 2014
ZFTA Translocations Constitute Ependymoma Chromatin Remodeling and Transcription FactorsOncogenic Mechanism of Ependymoma ZFTA-Fusion Proteins
R Kupp, L Ruff, S Terranova, E Nathan, S Ballereau, R Stark, ...
Cancer discovery 11 (9), 2216-2229, 2021
The system can't perform the operation now. Try again later.
Articles 1–20